UC San Diego Today company blog

GLP-1 drugs linked to lower death rates in colon cancer patients

In an analysis of more than 6,800 colon cancer patients across all University of California Health sites, researchers found that those taking glucagon-like peptide-1 (GLP-1) medications were less than half as likely to die within five years compared to those who weren’t on the drugs (15.5% vs. 37.1%
Points
241
HN comments
203
Submissions
1
Cited by
0 commenters

Science & Space2025

On Hacker News

SubmittedTitle on HNPointsComments
Nov 12, 2025GLP-1 drugs linked to lower death rates in colon cancer patients by gmays241203

More from UC San Diego Today

All 11 posts →

Related posts from the same era